Aurobindo Pharma has acquired the Generis group in Portugal (subject to the fulfilment of certain anti-trust approvals), through its step down subsidiary Agile Pharma (Netherlands) for a consideration of €135 million (Rs. 985 crore). The consideration is proposed to be financed via European debt
about 6 hrs 31 min 47 sec ago
With reference to the earlier letter dated January 14, 2017, Jain Irrigation Systems Ltd has now informed BSE that Companys Wholly owned subsidiary, Jain International Trading B.V, Netherlands (the "Company") has mandated Deutsche Bank and J.P. Morgan as Joint Global Coordinators, Joint Bookrunners
2.30 PM Jan 17th
Cosmo Films Ltd has informed BSE that CF Global Holding Mauritius Ltd, a wholly owned subsidiary of Cosmo Films Limited has ceased its activities and filed an application for winding up under section 309(1)(d) of the Companies Act, 2001 of Mauritius. Consequently, the shares of CF (Netherlands
5.23 PM Jan 16th
(Netherlands) Holdings Limited B.V. (hither to held by CF Global Holding Mauritius Limited) stand transferred to the Company resulting into CF (Netherlands) Holding Limited B.V. becoming a direct wholly owned subsidiary of the Company with effect from January 12, 2017.
5.19 PM Jan 16th
softened. "You can see how mid-caps have performed. Flows continue to come to domestic mutual funds. So it (the volatility) is more fund flow Driven. Further, concerns regarding Italy being a part of the European Union, and elections in France, Germany, and the Netherlands will also be watched out
11.40 AM Jan 16th
firm sold the flowers at a deep discount to the Dubai company, which would later re-sell them at a much higher price to a third wholesaler in the Netherlands. All the firms in the structure were owned by the same person, with the Dubai subsidiary making the highest profit.
10.38 PM Jan 14th
, Dani said. Currently, Aurobindo is among the top 10 generic players in seven European countries namely Portugal, Netherlands, France, Germany, Belgium, Spain and Italy. Aurobindo has shareholder approval to raise Rs 2,100 crore through a sale of shares, which it intends to use for global acquisitions
9.51 PM Jan 10th
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.